Comparison and analysis of the efficacy of ciprofol, propofol and etomidate in painless gastroenteroscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048237

Enrollment

Unknown

Registered

2021-07-05

Start date

2021-07-12

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control group:Propofol

Experimental group:Ciprofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Select ASA I-II patients, aged 18-65 years old, BMI <30kg/m^2; 2. For patients who are going to undergo gastroscopy or colonoscopy, their vital signs are within the requirements of the protocol (HR60-100 beats/min, SBP<160mmHg, DBP<100mmHg), and there is no contraindication to sedation and general anesthesia.

Exclusion criteria

Exclusion criteria: Severe heart and lung disease, acute perforation of upper gastrointestinal tract, severe snoring or obesity, allergy to anesthesia or sedative drugs, mental disorders, etc.

Design outcomes

Primary

Measure	Time frame
Success rate of anesthesia induction;	—

Secondary

Measure	Time frame
Additional medication situation;Waking hours;The incidence of respiratory depression, apnea, and hypoxia;	—

Countries

China

Contacts

Public ContactXia Leqiang

Deyang People's Hospital

649385448@qq.com+86 13547098458

Outcome results